FIELD: medicine, oncology, chemical-pharmaceutical industry, pharmacy.
SUBSTANCE: invention can be used in clinical practice for treatment of oncological diseases. Invention proposes an allogenic preparation from human placenta based on nucleoproteids complex fragmented to 200-2000 nucleotide pairs and comprising, wt.-%: DNA 60-80; nuclear matrix proteins, 20-40. The advantage of invention involves the presence of complex pharmaceutical activity and provides antitumor, antitoxic and radioprotecting effect of the preparation.
EFFECT: valuable medicinal properties of preparation.
3 cl, 2 tbl, 1 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
ONCOTHERAPY | 2008 |
|
RU2387456C1 |
METHOD OF TREATING ONCOLOGICAL DISEASES | 2012 |
|
RU2490028C1 |
METHOD OF TREATING CANCER | 2009 |
|
RU2429019C2 |
METHOD OF TREATING ONCOLOGICAL DISEASES | 2010 |
|
RU2489169C2 |
METHOD FOR TREATING ONCOLOGICAL DISEASES | 2018 |
|
RU2675233C1 |
METHOD OF TREATING ASCITIC CARCINOMA | 2015 |
|
RU2595864C1 |
METHOD OF CANCER TREATMENT | 2007 |
|
RU2345792C2 |
METHOD FOR TREATING DISEASES | 2006 |
|
RU2322264C1 |
METHOD FOR ERADICATION OF INITIATING CANCER STEM CELLS | 2013 |
|
RU2542410C1 |
METHOD OF OBTAINING STIMULATED DENDRITE CELLS FOR INDUCTION OF IMMUNE RESPONSE AGAINST HUMAN TUBERCULOSIS | 2009 |
|
RU2401664C1 |
Authors
Dates
2004-08-20—Published
2003-05-27—Filed